Zevra Therapeutics Inc.

NASDAQ: ZVRA · Real-Time Price · USD
9.28
0.27 (3.05%)
At close: Aug 20, 2025, 3:59 PM
9.38
1.08%
After-hours: Aug 20, 2025, 07:54 PM EDT

Zevra Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
25.88M 20.4M 12.04M 3.69M 4.45M 3.42M 13.22M 2.9M 8.47M 2.88M 2.32M 2.87M 1.3M 3.96M 2.58M 1.97M 11.99M 12.12M
Cost of Revenue
12.38M 1.34M 1.37M 2.3M 3.57M 3.27M 2.79M 144K 677K 125K 143K 141K 51K 8K 59K n/a 1M 1M
Gross Profit
13.5M 19.06M 10.68M 1.39M 876K 160K 10.43M 2.75M 7.79M 2.75M 2.18M 2.73M 1.25M 3.96M 2.52M 1.97M 10.99M 11.12M
Operating Income
-71.04M -5.36M -15.42M -27.31M -23.8M -20.49M -14.67M -15.36M -6.64M -12.92M 9.17M -6.63M -7.1M -1.86M -2.84M -2.22M 5.83M 6.96M
Interest Income
n/a n/a -73K 1.05M 270K 929K 208K 1.74M 1.55M 1.04M 590K 218K 366K 107K 112K 137K n/a 8K
Pretax Income
76.91M -1.92M -20.37M -33.23M -19.86M -16.69M -15.15M -10.19M -5.16M -11.87M -9.05M -6.65M -24.76M -1.87M -2.67M -1.76M 6.2M -10.3M
Net Income
74.71M -3.1M -35.74M -33.23M -19.93M -16.62M -15.15M -10.37M -5.08M -11.77M -9.02M -6.62M -24.04M -1.86M -2.7M -1.76M 6.2M -10.3M
Selling & General & Admin
20.78M 19.55M 16.13M 16.21M 12.6M 9.93M 14.66M 5.82M 7M 6.83M 5.08M 3.97M 3.56M 2.73M 2.56M 1.95M 2.31M 1.89M
Research & Development
3.43M 3.26M 9.91M 10.95M 10.52M 10.71M 10.45M 12.3M 7.43M 8.84M -11.31M 5.38M 4.79M 3.08M 2.81M 2.24M 2.85M 2.27M
Other Expenses
n/a 1.61M 54K 1.54M 1.55M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
24.21M 24.42M 26.09M 28.7M 24.67M 20.65M 25.1M 18.11M 14.44M 15.68M -6.23M 9.36M 8.35M 5.82M 5.37M 4.19M 5.15M 4.16M
Interest Expense
2.01M -1.97M 2.19M 1.26M 2.11M 735K 756K 366K 197K 182K 18K 124K 36K 5K 5K 6K 25K 349K
Selling & Marketing Expenses
n/a n/a 14.52M n/a 11M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
38.21M 25.76M 27.46M 31M 28.24M 23.91M 27.89M 18.26M 15.12M 15.8M -6.09M 9.5M 8.4M 5.82M 5.42M 4.19M 6.15M 5.16M
Income Tax Expense
2.2M -1.18M 15.37M n/a 70K -70K n/a 177K -74K -103K -34K -33K -715K -4K 34K 6K -39K n/a
Shares Outstanding (Basic)
54.78M 54.1M 53.67M 47.81M 41.9M 41.78M 37.9M 34.72M 33.9M 34.47M 34.51M 34.49M 34.45M 34.51M 35.35M 35.22M 29.17M 19.15M
Shares Outstanding (Diluted)
56.32M 54.1M 53.67M 47.81M 41.9M 41.78M 37.9M 34.72M 33.9M 34.47M 34.51M 34.49M 34.45M 34.51M 35.35M 35.22M 29.17M 19.15M
EPS (Basic)
1.36 -0.06 -0.67 -0.69 -0.48 -0.4 -0.4 -0.3 -0.15 -0.34 -0.26 -0.19 -0.7 -0.05 -0.08 -0.05 0.21 -0.54
EPS (Diluted)
1.21 -0.06 -0.67 -0.69 -0.48 -0.4 -0.4 -0.3 -0.15 -0.34 -0.26 -0.19 -0.7 -0.05 -0.08 -0.05 0.21 -0.54
EBITDA
-71.04M 1.7M -16.53M -29.3M -16.18M -14.39M -13.88M -13.44M -4.88M -12.75M -8.74M -6.13M -24.54M -1.8M -2.6M -1.69M 5.9M -9.88M
EBIT
78.92M 52K -18.17M -30.91M -17.75M -15.96M -14.67M -13.5M -4.96M -13.14M -9.04M -6.53M -24.72M -1.86M -2.66M -1.75M 6.23M -9.95M
Depreciation & Amortization
1.65M 1.65M 1.65M 1.62M 1.56M 1.56M 787K 62K 78K 79K 300K 398K 181K 65K 64K 65K 64K 64K